Mengxi Jiang1, Meishu Xu1, Songrong Ren1, Kyle W Selcer1, Wen Xie1,2. 1. Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania. 2. Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Abstract
BACKGROUND AND AIM: Sulfotransferase (SULT)-mediated sulfation and steroid sulfatase (STS)-mediated desulfation represent two critical mechanisms that regulate the chemical and functional homeostasis of endogenous and exogenous molecules. STS catalyzes the hydrolysis of steroid sulfates to form hydroxysteroids. Oxygenated cholesterol derivative oxysterols are known to be endogenous ligands of the liver X receptor (LXR), a nuclear receptor with anti-cholestasis activity, whereas the sulfated oxysterols antagonize LXR signaling. The conversion of sulfated oxysterols to their non-sulfated counterparts is catalyzed by STS. The aim of this study is to determine whether STS can alleviate cholestasis by increasing the activity of LXR. METHODS: Liver-specific STS transgenic mice were created and subject to the lithocholic acid (LCA)-induced model of cholestasis. RESULTS: Transgenic overexpression of STS in the liver promoted bile acid elimination and alleviated LCA-induced cholestasis. The protective effect of the STS transgene was associated with the activation of LXR and induction of LXR target genes, likely because of the increased conversion of the antagonistic oxysterol sulfates to the agonistic oxysterols. CONCLUSIONS: STS has a novel function in controlling the homeostasis of bile acids by regulating endogenous LXR ligands.
BACKGROUND AND AIM: Sulfotransferase (SULT)-mediated sulfation and steroid sulfatase (STS)-mediated desulfation represent two critical mechanisms that regulate the chemical and functional homeostasis of endogenous and exogenous molecules. STS catalyzes the hydrolysis of steroid sulfates to form hydroxysteroids. Oxygenated cholesterol derivative oxysterols are known to be endogenous ligands of the liver X receptor (LXR), a nuclear receptor with anti-cholestasis activity, whereas the sulfated oxysterols antagonize LXR signaling. The conversion of sulfated oxysterols to their non-sulfated counterparts is catalyzed by STS. The aim of this study is to determine whether STS can alleviate cholestasis by increasing the activity of LXR. METHODS: Liver-specific STS transgenic mice were created and subject to the lithocholic acid (LCA)-induced model of cholestasis. RESULTS: Transgenic overexpression of STS in the liver promoted bile acid elimination and alleviated LCA-induced cholestasis. The protective effect of the STS transgene was associated with the activation of LXR and induction of LXR target genes, likely because of the increased conversion of the antagonistic oxysterol sulfates to the agonistic oxysterols. CONCLUSIONS: STS has a novel function in controlling the homeostasis of bile acids by regulating endogenous LXR ligands.
Entities:
Keywords:
Bile acid; Cholestasis; Liver X receptor; Steroid sulfatase; Toxicity
Authors: Hirdesh Uppal; Simrat P S Saini; Antonio Moschetta; Ying Mu; Jie Zhou; Haibiao Gong; Yonggong Zhai; Songrong Ren; George K Michalopoulos; David J Mangelsdorf; Wen Xie Journal: Hepatology Date: 2007-02 Impact factor: 17.425
Authors: Joyce J Repa; Knut E Berge; Chris Pomajzl; James A Richardson; Helen Hobbs; David J Mangelsdorf Journal: J Biol Chem Date: 2002-03-18 Impact factor: 5.157
Authors: Yongjie Ma; Leyuan Xu; Daniel Rodriguez-Agudo; Xiaobo Li; Douglas M Heuman; Phillip B Hylemon; William M Pandak; Shunlin Ren Journal: Am J Physiol Endocrinol Metab Date: 2008-10-14 Impact factor: 4.310
Authors: Simrat P S Saini; Junichiro Sonoda; Li Xu; David Toma; Hirdesh Uppal; Ying Mu; Songrong Ren; David D Moore; Ronald M Evans; Wen Xie Journal: Mol Pharmacol Date: 2004-02 Impact factor: 4.436
Authors: Ian T Cook; Zofia Duniec-Dmuchowski; Thomas A Kocarek; Melissa Runge-Morris; Charles N Falany Journal: Drug Metab Dispos Date: 2009-07-09 Impact factor: 3.922